News Daily News GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm Caitlin E. Cox February 26, 2025
News Conference News AHA 2024 SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity Michael O'Riordan November 16, 2024
News Conference News ESC 2023 ESC Focused Update on HF Synthesizes New Trial Data for Practical Use L.A. McKeown September 01, 2023
News Daily News New AHA/ACC Performance and Quality Metrics for Coronary Revascularization Michael O'Riordan July 28, 2023
News Daily News New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization Michael O'Riordan July 20, 2023
News Daily News AHA Scientific Statement Addresses Health Disparities in PAD L.A. McKeown June 23, 2023
News Daily News Many ESC Guideline Recommendations Out of Reach in Poorer Regions Michael O'Riordan November 29, 2022
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022
News Conference News EAS 2022 FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses Michael O'Riordan May 26, 2022
News Daily News New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT Michael O'Riordan December 09, 2021
News Daily News Diabetes Progression in Statin-Treated Patients: VA Data Michael O'Riordan October 06, 2021
News Daily News Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care Shelley Wood May 27, 2021
News Daily News Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms Michael O'Riordan April 02, 2021
News Daily News Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval Michael O'Riordan March 03, 2021
News Daily News Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD Michael O'Riordan December 07, 2020
News Conference News ESC 2020 EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF Michael O'Riordan August 28, 2020
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Daily News AstraZeneca Strives to Block Generic Crestor as Observers Call Foul Michael O'Riordan July 13, 2016
News Industry News First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit June 09, 2015